首页> 外文期刊>BMC Pulmonary Medicine >Barriers to and competency with the use of metered dose inhaler and its impact on disease control among adult asthmatic patients in Ethiopia
【24h】

Barriers to and competency with the use of metered dose inhaler and its impact on disease control among adult asthmatic patients in Ethiopia

机译:使用计量剂量吸入器的障碍和能力及其对埃塞俄比亚成人哮喘患者疾病控制的影响

获取原文
           

摘要

Asthma is one of the chronic diseases which affects the airway, and inhalers are the preferred medications to treat this problem. Improper inhalational technique leads to decreased efficacy of the medication by reducing its deposition in the lungs. The aim of this study was to assess the barriers to and competency with the use of Metered Dose Inhaler (MDI) and its impact on disease control among adult asthmatic patients. A prospective cross-sectional study was conducted in University of Gondar comprehensive specialized hospital outpatient department (OPD) chronic follow up from 12-March-2018 to 15-May- 2018. Patients were interviewed face to face with questions which determined their competency, asthma control level and barriers for inhaler use. Overall, 307 asthmatic patients were included in the study. More than half of participants were females, 170 (55.4%) and lived in urban area 185 (60.3%). The mean age of the respondents was 51.77?years with a standard deviation of ±15.40. The cost of medication, 282 (91.9%) and the perception that medication should be used in response to symptoms but not on a regular basis 277 (90.2%) were the most identified barriers. Only 56 (18.2%) were competent for Metered Dose Inhaler use (MDIU) and 17 (5.5%) patients had well controlled asthma. Being not competent AOR 0.168[0.41–0.687] was one of the factors decreasing asthma control. Generally from this study, cost of the medication and the perception that medication should be used only for symptoms were the major identified barriers that affect the MDI use among asthmatic patients. Patients show very poor competence to their MDI which in turn led to poor asthma control. So, patients need to be taught the correct inhaler technique in the hospital and pharmacy while they came for follow up every time.
机译:哮喘是影响通气道的慢性疾病之一,吸入器是治疗该问题的优选药物。不正确的吸气技术通过降低肺部沉积来降低药物的疗效。本研究的目的是评估使用计量剂量吸入器(MDI)的障碍和能力及其对成人哮喘患者中疾病对照的影响。在2018年3月至2018年3月15日至5月15日至5月15日,在戈尼尔综合专业医院门诊部(OPD)的大学进行了一项潜在的横断面研究。面对患者的兴趣,哮喘患者面对面面对面的面对面。吸入器使用的控制水平和障碍。总体而言,研究中包含307名哮喘患者。一半以上的参与者是女性,170名(55.4%),住在185个(60.3%)。受访者的平均年龄为51.77岁,标准差为±15.40。药物的成本,282(91.9%)和治疗应响应症状而且不定期使用的感知,但不定期使用277(90.2%)是最识别最识别的障碍。只有56次(18.2%)的计量剂量吸入器使用(MDIU)和17例(5.5%)患者患有良好控制的哮喘。不受竞争力的AOR 0.168 [0.41-0.687]是降低哮喘控制的因素之一。通常来自这项研究,药物的成本及其仅用于症状的药物的感知是影响哮喘患者MDI使用的主要识别障碍。患者表现出对他们的MDI的竞争力非常差,导致哮喘控制差。因此,患者需要在医院和药房中教导正确的吸入技术,同时每次都在跟进。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号